# FDA Inspection 1025621 - Reproductive Genetic Innovations LLC - September 11, 2017

Source: https://www.keypedia.com/records/fda_inspections/reproductive-genetic-innovations-llc/6b980aac-322f-4087-be7c-0ed986c35c75
Source feed: FDA_Inspections

> FDA Inspection 1025621 for Reproductive Genetic Innovations LLC on September 11, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1025621
- Company Name: Reproductive Genetic Innovations LLC
- Inspection Date: 2017-09-11
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1207914 - 2023-05-03](https://www.keypedia.com/records/fda_inspections/reproductive-genetic-innovations-llc/97309b5e-8121-4501-9b01-b2278d6944b6)
- [FDA Inspection 891241 - 2014-08-13](https://www.keypedia.com/records/fda_inspections/reproductive-genetic-innovations-llc/d3db799f-af5e-4b97-b013-95b3f8bd6631)
- [FDA Inspection 631545 - 2009-11-24](https://www.keypedia.com/records/fda_inspections/reproductive-genetic-innovations-llc/7dd0dbac-ded5-469d-8809-3622b2c9329f)

Company: https://www.keypedia.com/companies/reproductive-genetic-innovations-llc/e4f3b8d5-6d25-4554-bc58-e596a3d51e3b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d